Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000726408 | SCV000344445 | uncertain significance | not provided | 2017-11-27 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000726408 | SCV000521295 | uncertain significance | not provided | 2017-01-27 | criteria provided, single submitter | clinical testing | The c.3838 T>C variant has been reported previously, using alternate nomenclature, in an individual with progressive familial intrahepatic cholestasis III (Chinnaratha et al. 2013). The c.3838 T>C variant was not observed in approximately 6500 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations. The c.3838 T>C nucleotide substitution results in the extension of the protein by 19 new amino acids, denoted p.X1280RextX19. Whether or not this extension affects normal protein function is not known in the absence of RNA/functional studies. In summary, based on the currently available information, it is unclear whether this variant is a pathogenic variant or a rare benign variant. |
Rolfs Rare Disease Consulting, |
RCV003485571 | SCV004232490 | likely pathogenic | Progressive familial intrahepatic cholestasis type 3 | 2019-01-01 | criteria provided, single submitter | clinical testing |